Cargando…
Blood‐brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein‐β in patients with subcortical small‐vessel disease
INTRODUCTION: Subcortical small‐vessel disease (SSVD) is the most common vascular cognitive disorder. However, because no disease‐specific cerebrospinal fluid (CSF) biomarkers are available for SSVD, our aim was to identify such markers. METHODS: We included 170 healthy controls and patients from th...
Autores principales: | Kettunen, Petronella, Bjerke, Maria, Eckerström, Carl, Jonsson, Michael, Zetterberg, Henrik, Blennow, Kaj, Svensson, Johan, Wallin, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949877/ https://www.ncbi.nlm.nih.gov/pubmed/35356486 http://dx.doi.org/10.1002/dad2.12296 |
Ejemplares similares
-
Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease
por: Jeppsson, Anna, et al.
Publicado: (2022) -
Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
por: Wallin, Anders, et al.
Publicado: (2016) -
Neuronal and Glia-Related Biomarkers in Cerebrospinal Fluid of Patients with Acute Ischemic Stroke
por: Hjalmarsson, Clara, et al.
Publicado: (2014) -
Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid
por: Bjerke, Maria, et al.
Publicado: (2010) -
Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease(2)
por: Wallin, Anders, et al.
Publicado: (2018)